0
Babies Need More Formula Now Act of 2022
12/30/2022, 12:04 AM
Summary of Bill HR 7830
The bill aims to increase access to formula for families in need by providing funding for programs that distribute formula to low-income households. It also seeks to improve the availability of formula in stores and pharmacies by incentivizing manufacturers to increase production.
Additionally, the Babies Need More Formula Now Act of 2022 includes provisions to ensure the safety and quality of formula products, such as requiring manufacturers to adhere to strict guidelines and regulations set by the Food and Drug Administration. Overall, this bill is designed to address the critical need for formula for infants and young children, particularly those from low-income families. By increasing access to formula and ensuring its safety and quality, the Babies Need More Formula Now Act of 2022 aims to improve the health and well-being of vulnerable populations.
Congressional Summary of HR 7830
Babies Need More Formula Now Act of 2022
This bill addresses the regulation of infant formula, including by authorizing the Food and Drug Administration (FDA) to waive certain requirements related to importation.
The FDA may waive labeling requirements related to the importation (or distribution or sale) of infant formula from a country with requirements that provide a similar assurance of safety as U.S. requirements.
The FDA must, when appropriate, enter into arrangements to harmonize U.S. regulatory requirements pertaining to infant formula with the requirements of other nations.
The bill imposes time lines for the FDA to respond to submissions for market approval for new infant formula.
The FDA must also issue guidance as to what types of changes in the ingredients of infant formula, if any, may not require a new growth study to meet FDA requirements.
The bill also authorizes a person to import, without prior notice to the FDA, up to a three-month supply of infant formula for personal use from a country with formula safety standards similar to U.S. standards, such as Canada.
Before recommending or requiring a recall of infant formula due exclusively to a labeling deficiency, the FDA must ensure that the recall will not negatively affect the supply of formula in the United States.
The bill also requires the FDA to (1) notify Congress no later than 24 hours after initiating a formula recall, and (2) provide certain information to formula manufacturers about restarting production after an inspection of a manufacturing facility impacted by a recall.
